Combined Treatments of Magnetic Intra-Lysosomal Hyperthermia with Doxorubicin Promotes Synergistic Anti-Tumoral Activity

Doxorubicin is a cytotoxic drug used for the treatment of many cancer types. However, its significant dose-related adverse effects including cardiotoxicity may hamper its efficiency. Moreover, the multidrug resistance that appears during treatments limits anti-cancer therapies. Hyperthermia has been...

Descripción completa

Detalles Bibliográficos
Autores principales: El Hajj Diab, Darine, Clerc, Pascal, Serhan, Nizar, Fourmy, Daniel, Gigoux, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071107/
https://www.ncbi.nlm.nih.gov/pubmed/29954075
http://dx.doi.org/10.3390/nano8070468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071107/
https://www.ncbi.nlm.nih.gov/pubmed/29954075
http://dx.doi.org/10.3390/nano8070468

Ejemplares similares